BioSpace News Archive

ApoCell, Inc. announced today the publication of biomarker results from the BEACON Phase 3 clinical trial that utilized Apocell’s proprietary circulating tumor cell enrichment system, ApoStream®.

Protagonist Therapeutics, Inc. today reported that on Sept. 15, 2018, it issued an inducement award to Carter King, the Company’s recently hired Vice President of Business Development, in accordance with the terms of Mr. King’s employment offer letter.

PLEXIS Healthcare System and Santéch announced a strategic partnership to empower provider network management and claims administration for payers across the country and beyond.

eptune Technologies & Bioressources Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT) announces that its shareholders have approved at the Annual Meeting of Shareholders held on August 15, 2018, the change of the Company’s legal name to Neptune Wellness Solutions Inc / Neptune Solutions Bien-Être Inc.,

In the newest rounds of grants marking its 20th anniversary, Hyundai Hope On Wheels celebrates National Childhood Cancer Awareness Month by awarding grants totaling $500,000

Benitec Biopharma Limited (“Benitec” or the “Company”) (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW), a clinical-stage biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference (ddRNAi) platform combining RNA interference with gene therapy, today announced that Gregory R. Reyes, M.D., Ph.D., has joined the company as Senior Scientific Advisor.

Quadrant Biosciences Inc., a developer of novel diagnostic technologies, has been awarded a $2 million Phase II Small Business Technology Transfer (STTR) grant from the National Institutes of Health (NIH) for the refinement and commercialization of an epigenetic autism spectrum disorder (“ASD”) diagnostic test.

Multi-Center Study to Evaluate Innovative Minimally Invasive Treatment for Functional Mitral Regurgitation

The development of the backup compound will be used for treating patients with limited therapeutic options for the treatment of solid tumors

New brain performance monitoring and training solution helps users tackle the massive impact of brain hacking